CD34 and Alzheimer disease: and Bigalke et al. [3] demonstrated that the number of CD34+ cells was significantly upregulated in AD patients as opposed to Kong et al. [9], Lewis et al. [11], and Maler et al. [10] who found that AD patients had decreased levels of circulating CD34+ cells in comparison to cognitively normal subjects.